Preventing asthma - are we ready to translate epidemiological and mechanistic studies into reality?
Asthma is the most prevalent chronic disease in children. Whilst progress has been made in the development of novel biologics as therapy for severe asthma, the involved costs are enormous thus enabling therapy of a limited number of patients affected by severe illness. Therefore, the quest for preventive approaches targeting young children before the onset of disease (primary prevention) or after first signs of disease in children at risk (secondary prevention) has moved forward rapidly with some novel promising approaches on the near horizon.
The aims of this ERS research seminar were:
- To bring together the key players in the field of primary prevention of asthma
- Review state-of-the-art studies including basic mechanisms, animal studies, epidemiological studies and ongoing and proposed intervention studies
- To highlight the areas of uncertainly in the above areas, by peer-led critical discussion
- To educate and inspire Early Career Members (ECMs) about primary prevention
- To write and publish a position statement on prevention of asthma